Ishiguro K - Search Results

1

DLEU1 promotes oral squamous cell carcinoma progression by activating interferon-stimulated genes.

Hatanaka Y, Niinuma T, Kitajima H, Nishiyama K, Maruyama R, Ishiguro K, Toyota M, Yamamoto E, Kai M, Yorozu A, Sekiguchi S, Ogi K, Dehari H, Idogawa M, Sasaki Y, Tokino T, Miyazaki A, Suzuki H. Hatanaka Y, et al. Among authors: ishiguro k. Sci Rep. 2021 Oct 14;11(1):20438. doi: 10.1038/s41598-021-99736-5. Sci Rep. 2021. PMID: 34650128 Free PMC article.

2

Molecular diagnostics of a single drug-resistant multiple myeloma case using targeted next-generation sequencing.

Ikeda H, Ishiguro K, Igarashi T, Aoki Y, Hayashi T, Ishida T, Sasaki Y, Tokino T, Shinomura Y. Ikeda H, et al. Among authors: ishiguro k. Onco Targets Ther. 2015 Oct 5;8:2805-15. doi: 10.2147/OTT.S86515. eCollection 2015. Onco Targets Ther. 2015. PMID: 26491355 Free PMC article.

3

The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway.

Kurihara H, Maruyama R, Ishiguro K, Kanno S, Yamamoto I, Ishigami K, Mitsuhashi K, Igarashi H, Ito M, Tanuma T, Sukawa Y, Okita K, Hasegawa T, Imai K, Yamamoto H, Shinomura Y, Nosho K. Kurihara H, et al. Among authors: ishiguro k. Oncotarget. 2016 Mar 15;7(11):12704-17. doi: 10.18632/oncotarget.7260. Oncotarget. 2016. PMID: 26871294 Free PMC article.

4

DOT1L inhibition blocks multiple myeloma cell proliferation by suppressing IRF4-MYC signaling.

Ishiguro K, Kitajima H, Niinuma T, Ishida T, Maruyama R, Ikeda H, Hayashi T, Sasaki H, Wakasugi H, Nishiyama K, Shindo T, Yamamoto E, Kai M, Sasaki Y, Tokino T, Nakase H, Suzuki H. Ishiguro K, et al. Haematologica. 2019 Jan;104(1):155-165. doi: 10.3324/haematol.2018.191262. Epub 2018 Aug 31. Haematologica. 2019. PMID: 30171029 Free PMC article.

5

UHRF1 depletion and HDAC inhibition reactivate epigenetically silenced genes in colorectal cancer cells.

Niinuma T, Kitajima H, Kai M, Yamamoto E, Yorozu A, Ishiguro K, Sasaki H, Sudo G, Toyota M, Hatahira T, Maruyama R, Tokino T, Nakase H, Sugai T, Suzuki H. Niinuma T, et al. Among authors: ishiguro k. Clin Epigenetics. 2019 May 7;11(1):70. doi: 10.1186/s13148-019-0668-3. Clin Epigenetics. 2019. PMID: 31064417 Free PMC article.

6

Aggressive variant of splenic marginal zone lymphoma characterized using a cancer panel test and treated with rituximab-containing chemotherapy: A case report.

Ishiguro K, Sasaki Y, Takagi Y, Niinuma T, Suzuki H, Tokino T, Hayashi T, Takahashi T, Igarashi T, Matsuno Y. Ishiguro K, et al. Medicine (Baltimore). 2020 Aug 28;99(35):e21938. doi: 10.1097/MD.0000000000021938. Medicine (Baltimore). 2020. PMID: 32871937 Free PMC article.

7

Dual EZH2 and G9a inhibition suppresses multiple myeloma cell proliferation by regulating the interferon signal and IRF4-MYC axis.

Ishiguro K, Kitajima H, Niinuma T, Maruyama R, Nishiyama N, Ohtani H, Sudo G, Toyota M, Sasaki H, Yamamoto E, Kai M, Nakase H, Suzuki H. Ishiguro K, et al. Cell Death Discov. 2021 Jan 12;7(1):7. doi: 10.1038/s41420-020-00400-0. Cell Death Discov. 2021. PMID: 33436557 Free PMC article.

8

An Integrated Epigenome and Transcriptome Analysis to Clarify the Effect of Epigenetic Inhibitors on GIST.

Niinuma T, Kitajima H, Yamamoto E, Maruyama R, Aoki H, Harada T, Ishiguro K, Sudo G, Toyota M, Yoshido A, Kai M, Nakase H, Sugai T, Suzuki H. Niinuma T, et al. Among authors: ishiguro k. Anticancer Res. 2021 Jun;41(6):2817-2828. doi: 10.21873/anticanres.15062. Anticancer Res. 2021. PMID: 34083271

9

Activated macrophages promote invasion by early colorectal cancer via an interleukin 1β-serum amyloid A1 axis.

Sudo G, Aoki H, Yamamoto E, Takasawa A, Niinuma T, Yoshido A, Kitajima H, Yorozu A, Kubo T, Harada T, Ishiguro K, Kai M, Katanuma A, Yamano HO, Osanai M, Nakase H, Suzuki H. Sudo G, et al. Among authors: ishiguro k. Cancer Sci. 2021 Oct;112(10):4151-4165. doi: 10.1111/cas.15080. Epub 2021 Aug 12. Cancer Sci. 2021. PMID: 34293235 Free PMC article.

10

Serum amyloid A1 recruits neutrophils to the invasive front of T1 colorectal cancers.

Yoshido A, Sudo G, Takasawa A, Aoki H, Kitajima H, Yamamoto E, Niinuma T, Harada T, Kubo T, Sasaki H, Ishiguro K, Yorozu A, Kai M, Katanuma A, Yamano HO, Osanai M, Nakase H, Suzuki H. Yoshido A, et al. Among authors: ishiguro k. J Gastroenterol Hepatol. 2023 Feb;38(2):301-310. doi: 10.1111/jgh.16055. Epub 2022 Nov 20. J Gastroenterol Hepatol. 2023. PMID: 36345658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

635 results

Search Page